DESCRIPTION
In this interview with Dr. Rick Doblin (almost one year after the last interview) we discuss the recent release of the (formerly) private letter the FDA sent to Lykos after the rejection of MDMA, which provides some additional insight into the FDA's motivations for rejecting MDMA as well as the role that Psymposia played. We also discuss the ongoing threats I'm receiving from Sarlo lawyers (attached) the very same people who funded Psymposia.
This interview is mostly video but the beginning has only sporadic images.
Read and download the FDA's CRLs: https://open.fda.gov/apis/transparency/completeresponseletters/